Promoter holding
64.27%
SP
Shrenik Pharma Pvt Ltd - Due diligence report
A 360° intelligence report on Shrenik Pharma Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth and distress…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Shrenik Pharma Pvt Ltd — 360° Intelligence Report
Generated from MCA filings & public records64/100
Trust Score
Moderate
Shrenik Pharma Pvt Ltd is assessed as Moderate with a Trust Score of 64/100. Shrenik Pharma Pvt Ltd is an active private limited indian non-government company incorporated in 1981, operating in the Chemicals and Materials sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 09 Jul 2026 from the latest processed filings. Shrenik Pharma Pvt Ltd snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
64/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
25/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 3 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 65/100 Moderate
- Liabilities ≈ 38% EBITDA - stretched.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 1 open (12.93 Lakh) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| The Maharashtra State Financial Corporation | 1 | 48.0 cr |
Compliance Score: 25/100 Caution Indicated
- Company status is Active as per MCA.
- Marked ACTIVE non-compliant (INC-22A).
- Last balance sheet is for Mar 2017 - filings overdue.
- Flagged by authority: MCA.
05
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| LAV KUMAR VADEHRA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VISHNU SHANKAR GURAV | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- VISHNU SHANKAR GURAV has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
06
Ownership & Group Intelligence
As per FY 2017 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Promoters hold a majority stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 90 · Distress 70
Growth signals & trust indicators
Steady revenue growth: +2.1x over 2 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
Operating for 45+ years.
Active EPFO - real payroll on record.
Distress signals & risk flags
Outside liabilities up 1.42 in a year.
Statutory filings appear overdue.
Compliance score is weak (25/100).
1 open charge(s) registered - assets are encumbered.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence50/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment64/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 12.93 Lakh already registered.
- Compliance gaps should be priced into terms.
Investor view85/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 7 events30 Sep 2017
Last AGM held
Annual general meeting
31 Mar 2017
Latest balance sheet
Filed with ROC
21 Mar 2011
Director ceased
OMPRAKASH BANSILAL SOOD
10 Jun 1997
Director appointed
VISHNU SHANKAR GURAV (Director)
01 Apr 1985
Director appointed
LAV KUMAR VADEHRA (Director)
01 Mar 1982
Charge created
The Maharashtra State Financial Corporation - 12.93 Lakh
28 Apr 1981
Incorporated
Registered with Roc Mumbai I
10
Key Observations
Auto-generated from the data aboveRevenue grew 2.1x over the last 2 financial year(s).
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
2 active director(s) / partner(s); review board churn before relying on management continuity.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2017 annual return.
| Company | CIN | Location |
|---|---|---|
| Techno Research For Advanced Systems Private Limited | U72200OR2013PTC017575 | Bhubaneswar, Orissa, India |
| Evax Healthcare Private Limited | U93030UP2010PTC042534 | Ghaziabad, Uttar Pradesh, India |
| Feminin Marketing Private Limited | U18101RJ2016PTC049111 | Jaipur, Rajasthan, India |
| Palak Pranjal Enterprises Private Limited | U52100UP2014PTC067574 | Ghaziabad, Uttar Pradesh, India |
| Silverline Telesolutions Infra Private Limited | U74140BR2015PTC024558 | Patna, Bihar, India |
| Avenue Life Sciences Private Limited | U52310UP2008PTC035228 | Lucknow, Uttar Pradesh, India |
| Zymic Pharmaceuticals Private Limited | U51397BR2011PTC017756 | Patna, Bihar, India |
| Aleit Advisory Private Limited | U51101WB2010PTC146452 | Kolkata, West Bengal, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Shrenik Pharma Pvt Ltd before audits and certifications: compliance score 25/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Shrenik Pharma Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Shrenik Pharma Pvt Ltd - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 64/100, distress signals and MSME payment-delay disclosures - know whether Shrenik Pharma Pvt Ltd pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Shrenik Pharma Pvt Ltd - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Shrenik Pharma Pvt Ltd an active company?
Shrenik Pharma Pvt Ltd has MCA status “Active” with a compliance score of 25/100 (Caution Indicated).
Is Shrenik Pharma Pvt Ltd financially healthy?
Shrenik Pharma Pvt Ltd has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Shrenik Pharma Pvt Ltd?
Its overall Trust Score is 64/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Shrenik Pharma Pvt Ltd?
Promoters hold a majority stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Shrenik Pharma Pvt Ltd have loans or charges against its assets?
1 open charge(s) are registered against its assets.
Is Shrenik Pharma Pvt Ltd up to date with its ROC filings?
Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 25/100 (Caution Indicated).
Is it risky to lend to Shrenik Pharma Pvt Ltd?
Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
